SciVision Biotech Inc
TWSE:1786
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Logah Technology Corp
TWSE:3593
|
TW |
|
M
|
Myrexis Inc
OTC:MYRX
|
US |
|
M
|
MJ Harvest Inc
OTC:MJHI
|
US |
|
C
|
Continental Petroleums Ltd
BSE:523232
|
IN |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| TW |
|
SciVision Biotech Inc
TWSE:1786
|
4.4B TWD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
10T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
29.7B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
37.1B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
94.9B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.5B USD |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
937.4B JPY |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.4B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD |
Loading...
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.9B CNY |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
36.4B CNY |
Loading...
|
Market Distribution
| Min | -197.7% |
| 30th Percentile | 13.7% |
| Median | 22.1% |
| 70th Percentile | 31.4% |
| Max | 400.8% |
Other Profitability Ratios
SciVision Biotech Inc
Glance View
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for SciVision Biotech Inc is 72%, which is below its 3-year median of 72.1%.
Over the last 3 years, SciVision Biotech Inc’s Gross Margin has increased from 66.7% to 72%. During this period, it reached a low of 66.7% on Dec 31, 2022 and a high of 74.8% on Sep 30, 2024.
